Cardio Diagnostics Holdings (NASDAQ: CDIO) is engaging directly with employers and benefits administrators at four national benefits conferences in June, where the company plans to discuss innovative approaches to cardiovascular disease prevention, risk assessment and cost management. The initiative comes as cardiovascular disease continues to drive a significant share of healthcare spending, with direct costs accounting for approximately 11% of all U.S. healthcare expenditures in 2020–2021, according to the American Heart Association.
A single heart attack or major cardiovascular event can have consequences that extend far beyond a patient's health, affecting employers, insurers and healthcare systems through higher medical costs, lost productivity and long-term care expenses. As cardiovascular disease remains one of the most expensive health conditions in the United States, organizations responsible for employee benefits are seeking new strategies to identify risk earlier and improve outcomes.
Cardio Diagnostics has developed a suite of solutions designed to provide earlier identification of cardiovascular risk and enable more targeted interventions and preventive care. The company's participation in these conferences underscores its commitment to addressing the burden of cardiovascular disease on the healthcare system and the economy.
For more information, please see the full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer. The latest news and updates relating to CDIO are available in the company's newsroom at https://ibn.fm/CDIO.
